瑞迈特收盘下跌3.28%，滚动市盈率40.61倍，总市值72.05亿元

Core Viewpoint - 瑞迈特's stock closed at 80.41 yuan, down 3.28%, with a rolling PE ratio of 40.61 times and a total market value of 7.205 billion yuan [1] Company Overview - 瑞迈特 specializes in manufacturing medical devices and consumables in the respiratory health sector, with key products including various types of sleep breathing machines and monitoring devices [1] - The company holds 633 domestic patents, including 107 invention patents, 390 utility model patents, and 136 design patents, as well as 202 international patents [1] Financial Performance - In Q1 2025, 瑞迈特 achieved an operating revenue of 265 million yuan, a year-on-year increase of 38.11%, and a net profit of 71.9314 million yuan, up 44.11% [2] - The sales gross margin for the same period was 49.57% [2] Market Position - 瑞迈特's PE ratio of 40.61 is below the industry average of 51.42 and the industry median of 37.44, ranking 82nd in the medical device sector [1][2] - The average market capitalization of the industry is 10.66 billion yuan, indicating that 瑞迈特's market value is significantly lower than the industry average [2] Shareholder Information - As of March 31, 2025, 瑞迈特 had 9,118 shareholders, an increase of 1,481 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares per shareholder [1]